STAT3 and neoplasm: miR-3619-5p inhibited tumor growth in vivo by inducing the phosphorylation of activator of transcription 3 (STAT3) and retinoblastoma protein (Rb1), thereby targeting PSMD10 to inhibit cell proliferation and induce G1 arrest [51].